Agreements for SCS

View Gallery

Published Date: 02 February 2007

STEM Cell Sciences, the Edinburgh-based biotechnology company, has announced that it has secured "material transfer" and "option to license" agreements to explore the use of L-particles and PREPS technology owned by drug discoverer Henderson Morley.

Page 1 of 1

Last Updated: 02 February 2007 10:07 AM
Source: Edinburgh Evening News
Location: Edinburgh
Related Topics: Cloning & stem cell research , Biotechnology

Bookmark:

Del.icio.us Post this story to Del.icio.us

Digg

Facebook

StumbleUpon Post this story to stumbleupon

Comment on this Story

In order to post comments you must Register or Sign In

RSS Feed of this article's comments

Delivery formats: RSS, Atom, Javascript & Email

More Biotechnology

More Biotechnology >>

More Cloning & stem cell research

More Cloning & stem cell research >>

Featured Advertising

Johnston Press Digital Publishing

Sister Newspapers:

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.

Sections

Other Sections

Topics

Other Sites